Outcome of Subsequent Therapies After 177Lu‐Vipivotide Tetraxetan for Metastatic Castrate‐Resistant Prostate Cancer: A Tertiary Cancer Center Experience

Conflicts of Interest Atish D Choudhury: Advisory board: Tolmar, Pfizer, Astellas, Janssen, Sanofi Aventis; Research Funding to Institution: Bayer, Pfizer, Eli Lilly, Sumitomo Pharma; Honoraria for speaking engagement: Bayer, Pfizer, Lantheus Alicia Morgans: Consulting: AAA, Novartis, Curium, Telix, Lantheus. Mary-Ellen Taplin: Advisory board: Blue Earth Diagnostics, Novartis. Xiao X.